Korsana Biosciences, Inc. (KRSA) vs uniQure N.V. (QURE)
- Korsana Biosciences, Inc. KRSA 32.38 −3.77%
- uniQure N.V. QURE 21.72 −3.55%
Korsana Biosciences, Inc. and uniQure N.V. are both Biotechnology companies. Korsana Biosciences, Inc. and uniQure N.V. are of similar size ($1.6B and $1.5B). Korsana Biosciences, Inc. grew revenue faster over the last twelve months: 30.8% against 30.2%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −1,350.7%) and the lower return on invested capital (−115.4% vs 0.00%). Across the 18 metrics below, Korsana Biosciences, Inc. leads on 12 and uniQure N.V. on 6.
Valuation
Profitability
| Metric | KRSA | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.49% | 65.16% |
| Operating margin | 0.00% | (1,071.53%) | 0.00% |
| Net margin | 0.00% | (1,350.73%) | 0.00% |
| Free cash flow margin | 0.00% | (864.67%) | 0.00% |
| Return on equity | (98.22%) | (157.61%) | (56.36%) |
| Return on assets | (82.29%) | (32.13%) | (48.04%) |
| Return on invested capital | (115.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack